Recent News & Comments About treatments for obesity
Brain rewiring offers slim hope for obesity epidemic
Weight-loss surgery helps people to think thin, which could open the door to new and gentler drug treatments for obesity
Arena shares soar as experts recommend approval for obesity drug
Shares of Arena Pharmaceuticals Inc nearly doubled in value after a panel of experts recommended approval of the company's obesity pill, a big step towards making it the first new diet drug on the U.S. ...
A Systems Approach to Solving America's Obesity Problem
Americans know they are fat. A staggering two-thirds of adults and one-third of children in the United States are overweight or obese, hampering the overall productivity and health of the nation. Obesity-related illness treatments cost an estimated $190.2 billion annually, for example, which is 21 percent of annual medical spending in the United??States. Researchers project ...
Arena obesity pill wins over U.S. advisers
SILVER SPRING, Maryland (Reuters) - An experimental obesity pill from Arena Pharmaceuticals Inc won the support of U.S. advisers on Thursday, as public health advocates push for new solutions to the nation's growing obesity epidemic. A panel of outside experts to the Food and Drug Administration voted 18 to 4 to recommend approval of lorcaserin, bringing the drug a step closer to U.S. approval ...
Research May Point to New Obesity Treatments
SUNDAY, May 6 (HealthDay News) -- Scientists who found a way to make white fat behave more like brown fat say their discovery could lead to new obesity treatments.
Obesity in the Workplace: A Disability You Must Accommodate?
(5/15) By Kristine E. Kwong, Esq, Musick, Peeler & Garrett, LLP One of the fastest-growing challenges in handling disabilities in the workplace is the concern over how to respond to obesity. Weight related diseases account for nearly ten percent of medical spending, everything from heart disease treatments to diabetes medications. Ultimately, these medical conditions will manifest itself in the ...
New inflammation hormone link may pave way to study new drugs for Type 2 diabetes
A new link between obesity and Type 2 diabetes found in mice could open the door to exploring new potential drug treatments for diabetes, University of Michigan Health System research has found.
US FDA staff focus on safety of Arena obesity pill
WASHINGTON (Reuters) - U.S. drug reviewers on Tuesday said Arena Pharmaceuticals Inc's obesity pill appeared to help people lose weight and was unlikely to cause tumors in humans, but questioned if the company had provided enough data to rule out heart problems. Lorcaserin is one of three new potential obesity treatments vying to gain U.S. approval and be the first new weight-loss treatment on ...
Apofore Founder Publishes Studies Identifying Apolipoprotein A-IV as New Potential Target for Type 2 Diabetes ...
Apofore Corporation today announced that its scientific founder at the University of Cincinnati, Patrick Tso, PhD, Professor in the Department of Pathology and Laboratory Medicine, has published new data demonstrating that the naturally occurring protein, Apolipoprotein A-IV , reduces blood sugar and increases insulin secretion in mouse models of diabetes.
People with Diabetes Living Longer Than Before
People with diabetes are living longer, according to a new report from the Centers for Disease Control and Prevention (CDC).
 |
|
Free Diet Articles
|
